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Summary
A 78-year-old male retired mathematician with severe
aortic stenosis, persistant atrial fibrillation, reluctance
to accept oral anticoagulation, and with suspected coro-
nary artery disease was referred for further manage-
ment. In a single intervention, the left atrial append-
age was occluded with a plug, double vessel coronary
artery disease was treated with drug-eluting stents,
and an aortic bioprosthesis was implanted transfem-
orally.
Case report
The patient with severe degenerative stenosis of a tricuspid
aortic valve complained of exertional chest pain and occa-
sional dizziness but no loss of consciousness. Severe aortic
stenosis had been diagnosed due to a murmur observed dur-
ing the occasion of a hospitalisation for a skiing accident
eight months earlier. Past medical history was remarkable
for persistant atrial fibrillation and hypertension. The elec-
trocardiogram showed atrial fibrillation at a rate of 96 bpm
with no evidence of bundle branch block. Transthoracic
echocardiography revealed a mean/peak gradient of 47/67 mm
Hg projecting an aortic valve area of 0.5 cm
2
, according to the
continuity equation. Left ventricular function was normal and
there was no pulmonary hypertension. Exercise treadmill
testing showed a mildly decreased exercise tolerance, repro-
duced the reported symptoms, and showed ST-deviations
without an exercise-induced drop of systolic blood pressure.
The patient refused to undergo open heart surgery and was
reluctant to continue oral anticoagulation for atrial fibrilla-
tion. He agreed to cardiac catheterisation with percutaneous
cardiac intervention.
Through a transfemoral venous approach and transseptal
puncture, the left atrial appendage was identified and anAm-
platzer cardiac Plug 20 mmwas positioned in the entry of the
appendage. A stable position of the device and complete oc-
clusion of the retroverted, single-lobulated appendage were
verified by angiography before the device was released from
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Figure 1
Left atrial appendage on cardiac catheterisation and transoesophageal
echocardiography.
Figure 2
Angiography and echocardiogaphic control after release
of the Amplatzer Cardiac Plug.
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the catheter (fig. 1–2). Thereafter, coronary angiography was
performed which showed significant stenosis of the mid left
anterior descending coronary artery (LAD) and the proximal
left circumflex coronary artery (LCX). Following successful
treatment with two everolimus-eluting stents, respectively
(fig. 3), angiography of the aorta and iliac artery was per-
formed to measure the aortic valvar annulus and assess the
peripheral access site. The patient qualified for implantation
of a Medtronic CoreValve bioprosthesis and a 18 French
sheath was introduced in the right femoral artery, as well as
a temporary transvenous pacemaker through a right jugular
access. After balloon dilatation of the degenerative aortic
valve with a Nucleus balloon 25 × 40 mm under rapid pacing,
the self-expandable bioprosthesis was deployed under fluoro-
scopic guidance (fig. 4). Periinterventional transoesophageal
echocardiography demonstrated an excellent result with neg-
ligible paravalvular regurgitation. Simultaneous invasive
measurement demonstrated a decrease in the mean trans-
valvular pressure gradient from 56 to 5 mm Hg. Closure of
the right femoral access site was performed under temporary
balloon occlusion of the right external iliac artery, from a con-
tralateral femoral access with a Prostar device. The inter-
vention was performed under general anaesthesia.
The further hospital course was uneventful. Postinterven-
tional transthoracic echocardiography confirmed the excel-
lent periinterventional result and the patient was discharged
home on the fourth postinterventional day, on double an-
tiplatelet therapy with acetylsalicylic acid (100 mg per day)
and Clopidogrel (75 mg per day).
Discussion
Percutaneous treatment strategies shorten hospital-
isation duration, accelerate time to recovery and en-
hance patient comfort. They have proven to be a valu-
able alternative to open heart surgery in an ever grow-
ing field of cardiac interventions. Coronary artery dis-
ease and atrial fibrillation are common findings in
elderly patients with severe aortic stenosis and are as-
sociated with an adverse prognosis [1]. Comprehensive
management in high-risk patients with aortic stenosis
and coronary artery disease has been suggested using
a hybrid approach with a staged procedure involving
initial percutaneous coronary intervention (PCI) fol-
lowed by valve replacement shortly thereafter [2]. Re-
cently, a combined approach using PCI and trans-
catheter aortic valve implantation has been proposed
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Figure 3
Percutaneous revascularisation of the mid-LAD (A) and proximal
LCX (B).
A
B
Figure 4
Concomitant LAA closure, double vessel revascularisation and aortic
valve implantation.
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for patients with complex coronary artery disease and
aortic valve stenosis in a small subset of patients [3]. In
our own experience of more than 160 patients under-
going transcatheter aortic valve implantation at our fa-
cility, 13% underwent concomitant PCI and 12% were
treated in a staged procedure, both with favorable
midterm results.
Atrial fibrillation increases the risk for embolic
stroke with emboli mostly originating from the left
atrial appendage. Whereas anticoagulation has proven
to be effective in the prevention of thromboembolic
events, it is associated with the hazard of severe bleed-
ing [4], particularly in elderly patients. Percutaneous
closure of the left atrial appendage has been demon-
strated to be not inferior to warfarin therapy in a re-
cent multicentre, randomised trial [5]. The technique
used here was derived from the well established clo-
sure technique for atrial shunts [6].
This is, to our knowledge, the first case of a con-
comitant PCI, transfemoral aortic valve implantation
and left atrial appendage closure in a single interven-
tion and demonstrates the feasibility of a combination
of different techniques during a single intervention in
appropriate patients. Even though such a combined in-
tervention is not in accordance with current guidelines
and hence cannot be recommended as a routine ap-
proach at this time, it is anticipated to be the next step
in percutaneous cardiac treatment.
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